Close-up of electrocardiogram (ECG) on digital display monitor.
Our Work

Latham & Watkins Advises Consonance Capital Partners on US$1.35 Billion Fund Formation

October 9, 2026
Multidisciplinary team led by members of the firm’s Investment Funds Practice represented the healthcare private equity firm in the formation of its oversubscribed third fund.

Consonance Capital Partners (Consonance), a leading US-based healthcare private equity firm, announced the closing of Consonance Private Equity III, L.P. (Fund III), with commitments totaling US$1.35 billion. After just under four months in the market, Consonance held its final close on Fund III at its hard cap in a heavily oversubscribed process. Consistent with its predecessor funds, Fund III will focus on investments in US healthcare companies in the lower and middle market.

Latham & Watkins LLP represented Consonance in the transaction with a team led by Investment Funds partners Andrea Schwartzman and Erin Bergey, with associate Ethan Cramer Gibbs. Advice was also provided on US tax matters by partner Greg Hannibal, with associate Nicholas Sun; and on funds regulatory matters by partners Laura Ferrell and Jennifer Tian.

Endnotes